Cross-linking_NN
of_IN
CD30_NN
induces_VBZ
HIV_NN
expression_NN
in_IN
chronically_RB
infected_VBN
T_NN
cells_NNS
._.

CD30_NN
,_,
a_DT
member_NN
of_IN
the_DT
tumor_NN
necrosis_NN
factor_NN
-LRB-_-LRB-
TNF_NN
-RRB-_-RRB-
receptor_NN
family_NN
,_,
is_VBZ
expressed_VBN
constitutively_RB
on_IN
the_DT
surface_NN
of_IN
the_DT
human_JJ
T_NN
cell_NN
line_NN
ACH-2_NN
,_,
which_WDT
is_VBZ
chronically_RB
infected_JJ
with_IN
human_JJ
immunodeficiency_NN
virus_NN
type-1_NN
-LRB-_-LRB-
HIV_NN
-RRB-_-RRB-
-1_CD
._.

We_PRP
demonstrate_VBP
that_IN
cross-linking_NN
CD30_NN
with_IN
an_DT
anti-CD30-specific_JJ
monoclonal_JJ
antibody_NN
,_,
which_WDT
mimics_VBZ
the_DT
described_VBN
biological_JJ
activities_NNS
of_IN
the_DT
CD30_NN
ligand_NN
-LRB-_-LRB-
CD30L_NN
-RRB-_-RRB-
,_,
results_VBZ
in_IN
HIV_NN
expression_NN
._.

CD30_NN
cross-linking_NN
does_VBZ
not_RB
alter_VB
proliferation_NN
of_IN
ACH-2_NN
cells_NNS
and_CC
the_DT
induction_NN
of_IN
HIV_NN
expression_NN
is_VBZ
not_RB
mediated_VBN
by_IN
endogenous_JJ
TNF_NN
alpha\/beta_NN
._.

Furthermore_RB
,_,
cross-linking_NN
of_IN
CD30_NN
leads_VBZ
to_TO
NF-kappa_NN
B_NN
activation_NN
and_CC
enhanced_VBN
HIV_NN
transcription_NN
._.

Thus_RB
,_,
CD30-CD30L_JJ
interactions_NNS
mediate_VBP
the_DT
induction_NN
of_IN
HIV_NN
expression_NN
by_IN
a_DT
kappa_NN
B-dependent_JJ
pathway_NN
that_WDT
is_VBZ
independent_JJ
of_IN
TNF_NN
._.

This_DT
mechanism_NN
may_MD
be_VB
important_JJ
in_IN
the_DT
activation_NN
of_IN
HIV_NN
expression_NN
from_IN
latently_RB
infected_JJ
CD4_NN
+_CC
T_NN
cells_NNS
,_,
especially_RB
in_IN
lymphoid_JJ
organs_NNS
where_WRB
cell_NN
to_TO
cell_NN
contact_NN
is_VBZ
conducive_JJ
to_TO
receptor-ligand_JJ
interactions_NNS
._.

